keyboard_arrow_up

3D cell culture market to grow at a CAGR of 23.6% The Market to reach USD 1345.2million by 2021

3D cell culture market to Grow at a CAGR of 23.6% by 2021 Asper Latest Market Research
The global 3D cell culture market size is expected to reach USD 1345.2million by 2021 from USD 466.8million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is segmented based on technology, application, end user, and region. The scaffold-based segment is expected to register the highest growth rate in the 3D cell culture market, by technology, during the forecast period. The high growth in this segment is attributed to the variety of material and structural choices for scaffold, due to which they are most preferred in various applications.
Based on end users, the 3D cell culture market is segmented into research laboratories & institutes, biotechnology & pharmaceutical industries, and hospitals & diagnostic centers. The biotechnology & pharmaceutical industries segment is expected to account for the largest share of the market in 2016. Increasing prevalence of cancer cases and the need for development of advanced drugs and therapies will drive the growth of this market.


Complete report on 3D Cell Culture Market spread across 158 pages, profiling 11 companies and supported with 65 tables and 72 figures is now available at http://www.rnrmarketresearch.com/3d-cell-culture-market-by-technology-scaffold-based-scaffold-free-application-cancer-cell-research-cell-based-assays-toxicity-screening-end-users-biotechnology-pharmaceuticals-industries-and-geography-g-st-to-2021-market-report.html



Geographically, the 3D cell culture market is dominated by North America, followed by Europe, Asia-Pacific, and Rest of the World (RoW). Growth in the North American segment is primarily driven by rising incidences of cancer, increasing government support in the form of grants and funding, expanding biopharmaceutical industry, and launch of new products in the market.


The major factors contributing to the growth of the 3D cell culture market include increasing incidences of cancer, growing awareness regarding the benefits of3D cell culture, rising regulatory approvals for cell culture-based vaccines, funding for cell-based research, and technological advancements. On the other hand, high cost of cell biology research and lack of infrastructure for cell-based research in emerging economies are the major factors restraining the growth of this market. The high growth potential in the Asia-Pacific region provides growth opportunities to players in the 3D cell culture market.


Inquire Before Buying: http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=628893


Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach and levels of output in order to remain successful in the 3D cell culture market.


Get a Sample Copy of This Report: http://www.rnrmarketresearch.com/contacts/request-sample?rname=628893
The major players in this market include 3D Biotek LLC (U.S.), Becton, Dickinson and Company(U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions, Inc. (U.S.), Kuraray Co. Ltd. (Japan), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Reinnervate Ltd, (a subsidiary of Repro CELL) (U.K.), and others.
Target Audience for this Report:
•    Pharmaceutical and Biopharmaceutical Companies
•    Manufacturers of Cell Culture Equipment
•    Contract Research Organizations
•    Life Science Research Institutes
•    Venture Capitalists
•    Research and Consulting Firms
Scope of the Report:
This report categorizes the 3D cell culture market into the following segments:
3D Cell Culture Market, By Technology
•    Scaffold-Based
o    Hydrogels/ECM Analogs
o    Solid Scaffolds
o    Micropatterned Surfaces
o    Others
•    Scaffold Free    
o    Attachment Resistant Surfaces
o    Suspension Cultures
3D Cell Culture Market, By Application
•    Cell-based Assays/Toxicity Screening
•    Cancer Cell Research
•    3D Printing/Microfluidics
•    Regenerative Medicine
•    In Vivo Applications for Stem Cell
3D Cell Culture Market, By End User
•    Research Laboratories & Institutes  
•    Biotechnology & Pharmaceutical Industries
•    Hospitals & Diagnostic Centers
•    Others
3D Cell Culture Market, By Region
•    North America
o    U.S.
o    Canada
o    Mexico
•    Europe
o    Germany
o    France
o    Italy
o    U.K.
o    Spain
o    RoE
•    Asia-Pacific
o    China
o    Japan
o    India
o    Republic of Korea
o    Australia
o    RoA
•    Rest of the World (RoW)